Kristie L. Kahl is vice president of content at MJH Life Sciences, overseeing CURE®, CancerNetwork®, the journal ONCOLOGY, Targeted Oncology, and Urology Times®. She has been with the company since November 2017.
She is a graduate of Rider University, where she acquired a Bachelors of Art in journalism, as well as a graduate of Temple University, where she received her Masters of Science in Sports Management.
Follow Kristie on Twitter at @KristieLKahl, or email her at kkahl@mjhlifesciences.com.
Seeking Support for Mental, Emotional Well-Being During Breast Cancer
October 13th 2023In this on-demand webinar series, CURE partnered with TOUCH, The Black Breast Cancer Alliance to offer advice and ways patients can seek support to ensure they are taking care of their mental and emotional health after a breast cancer diagnosis.
The Importance of Having Difficult Conversations After a Breast Cancer Diagnosis
October 13th 2023In this on-demand webinar series, CURE partnered with TOUCH, The Black Breast Cancer Alliance to highlight the importance of having difficult conversations with one’s family about a breast cancer diagnosis and its treatment.
Knowing Ones Rights When Working After a Cancer Diagnosis
May 30th 2023As part of its Speaking Out video series, CURE spoke with Joanna Fawzy Morales, Esq., from Triage Cancer, about working during a cancer diagnosis and its treatments, and what rights individuals have when it comes to employment and insurance.
Adding Nubeqa to Therapy May Reduce PSA Levels in Metastatic Hormone-Sensitive Prostate Cancer
May 1st 2023Men with metastatic hormone-sensitive prostate cancer treated with Nubeqa, androgen-deprivation therapy and docetaxel had reductions in PSA levels that were associated with improved overall survival and a prolonged time to PSA progression.